World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
75
Citations
16006
World Ranking
2016
National Ranking
52

Giulio C. Spagnoli publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Giulio C. Spagnoli sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 331 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Giulio C. Spagnoli D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Giulio C. Spagnoli sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 75 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Giulio C. Spagnoli is affiliated with the University Hospital of Basel in Switzerland. Their work focuses primarily on the fields of Medicine, Immunology, and Microbiology, with particular emphasis on Oncology and Immunology as leading subfields. This specialization includes contributions to Molecular Biology, Radiology, Nuclear Medicine and Imaging, and Pulmonary and Respiratory Medicine.

The main research topics addressed by Giulio C. Spagnoli encompass Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, and Immunotherapy and Immune Responses. Additional focal areas include Cancer Cells and Metastasis, CAR-T cell therapy research, T-cell and B-cell Immunology, and Cancer-related molecular mechanisms research.

The scientist has published extensively, with notable appearances in the following venues:

  • Cancers
  • Preprints.org
  • Nephrology Dialysis Transplantation
  • Scientific Reports
  • Cancer Immunology Research

Frequent collaborators include Giuseppe Sconocchia, Raoul A. Droeser, Benjamin Weixler, Luigi Terracciano, and Giandomenica Iezzi.

Key recent papers authored or coauthored by Giulio C. Spagnoli include:

  • Fibrosis and cancer: shared features and mechanisms suggest common targeted therapeutic approaches, 2020, Nephrology Dialysis Transplantation
  • Prognostic significance of CD8+ T-cells density in stage III colorectal cancer depends on SDF-1 expression, 2021, Scientific Reports
  • Infiltration by IL22-Producing T Cells Promotes Neutrophil Recruitment and Predicts Favorable Clinical Outcome in Human Colorectal Cancer, 2020, Cancer Immunology Research
  • Identification of TPM2 and CNN1 as Novel Prognostic Markers in Functionally Characterized Human Colon Cancer-Associated Stromal Cells, 2022, Cancers
  • Low Expression of Programmed Death 1 (PD-1), PD-1 Ligand 1 (PD-L1), and Low CD8+ T Lymphocyte Infiltration Identify a Subgroup of Patients With Gastric and Esophageal Adenocarcinoma With Severe Prognosis, 2020, Frontiers in Medicine

Best Publications

  • Clinical impact of programmed cell death ligand 1 expression in colorectal cancer.

    Raoul A. Droeser;Raoul A. Droeser;Christian Hirt;Christian Hirt;Carsten T. Viehl;Daniel M. Frey

  • Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells.

    Andreas Mackensen;Birgit Herbst;Ji-Li Chen;Gabriele Köhler

  • Three‐dimensional culture of melanoma cells profoundly affects gene expression profile: A high density oligonucleotide array study

    Sourabh Ghosh;Giulio C. Spagnoli;Ivan Martin;Sabine Ploegert

  • Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer

    A Lugli;G Iezzi;I Hostettler;M G Muraro

  • IFN-α2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells

    Elisabetta Padovan;Giulio C. Spagnoli;Maria Ferrantini;Michael Heberer

  • Melanoma Cells Present a MAGE-3 Epitope to CD4+ Cytotoxic T Cells in Association with Histocompatibility Leukocyte Antigen DR11

    Simona Manici;Tiziana Sturniolo;Maria Adele Imro;Juergen Hammer

  • Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells

    Tobias Schatton;Ute Schütte;Natasha Y. Frank;Qian Zhan

  • Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation.

    A Funaro;G C Spagnoli;C M Ausiello;M Alessio

  • Gut microbiota modulate T cell trafficking into human colorectal cancer

    Eleonora Cremonesi;Valeria Governa;Jesus Francisco Glaus Garzon;Valentina Mele

  • Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro

    Ciara Bocelli-Tyndall;L. Bracci;G. Spagnoli;A. Braccini

  • Genes encoding tumor-specific antigens are expressed in human myeloma cells

    N. Van Baren;F. Brasseur;D. Godelaine;G. Hames

  • Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer.

    Ulrich Guller;Paul Zajac;Annelies Schnider;Beatrix Bösch

  • The Interplay Between Neutrophils and CD8+ T Cells Improves Survival in Human Colorectal Cancer.

    valeria governa;Emanuele Trella;Valentina Mele;Luigi Tornillo

  • Microtubule-Depolymerizing Agents Used in Antibody–Drug Conjugates Induce Antitumor Immunity by Stimulation of Dendritic Cells

    Philipp Müller;Kea Martin;Sebastian Theurich;Jens Schreiner

  • Identification and Intracellular Location of MAGE-3 Gene Product

    Thomas Kocher;Elke Schultz-Thater;Fred Gudat;Christoph Schaefer

  • NK cells and T cells cooperate during the clinical course of colorectal cancer

    Giuseppe Sconocchia;Serenella Eppenberger;Giulio C Spagnoli;Luigi Tornillo

  • Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms.

    Evgeny Yakirevich;Edmond Sabo;Ofer Lavie;Salam Mazareb

  • Interdependence of CD3-Ti and CD2 activation pathways in human T lymphocytes.

    A. Alcover;C. Alberini;O. Acuto;L. K. Clayton

  • New dimensions in tumor immunology: what does 3D culture reveal?

    Chantal Feder-Mengus;Sourabh Ghosh;Sourabh Ghosh;Anca Reschner;Ivan Martin

  • CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a 'pro-/anti-tumour' approach to tumour host interaction in colorectal cancer.

    A Lugli;E Karamitopoulou;I Panayiotides;P Karakitsos

  • The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes.

    Urs Lüscher;Luis Filgueira;Antonio Juretic;Markus Zuber

Frequent Co-Authors

Michael Heberer
Michael Heberer University Hospital of Basel
Luigi Terracciano
Luigi Terracciano University Hospital of Basel
Ivan Martin
Ivan Martin University Hospital of Basel
Inti Zlobec
Inti Zlobec University of Bern
Alessandro Lugli
Alessandro Lugli University of Bern
Soldano Ferrone
Soldano Ferrone Harvard University
Achim A. Jungbluth
Achim A. Jungbluth Memorial Sloan Kettering Cancer Center
Lukas Bubendorf
Lukas Bubendorf University Hospital of Basel
Fabio Malavasi
Fabio Malavasi University of Turin
Francesco Zorzato
Francesco Zorzato University of Ferrara

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their careers in immunology-related healthcare fields, exploring online nursing degrees can be an excellent pathway. Programs like the fnp to acnp bridge program online offer specialized training for Family Nurse Practitioners looking to transition into Acute Care roles, a skill set valuable in immunology patient care.

Accelerated nursing programs are another popular option, especially for those eager to enter the healthcare workforce quickly. The nurse practitioner accelerated program provides a fast-tracked route to becoming a nurse practitioner, combining rigorous training with flexible online formats.

For individuals without a nursing background but interested in healthcare, online pathways like online adn programs for non nurses can facilitate entry into nursing roles, laying a strong foundation for immunology-related positions.

Many students also seek programs that balance quality with accessibility. Options such as the easiest absn programs to get into allow learners to gain a Bachelor of Science in Nursing efficiently, creating opportunities to specialize further in immunology or related healthcare fields.

Best Scientists Citing Giulio C. Spagnoli

Trending Scientists

Recently Published Articles